Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Bares Capital Management MRK trades

Brian Bares

Bares Capital Management Merck & Company Inc stake

total: 156

Trades details

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2014 Q1
Held for:
4 quarters
Latest activity:
2015 Q1
According to 2025 Q3 report, Bares Capital Management doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $56.67 for "buy" trades and estimated average "sell" price is $56.67. Bares Capital Management first purchased MRK in 2014 Q1, initially acquiring 3,794 shares. Since the initial investment in Merck & Company Inc (MRK), Bares Capital Management has made 1 more transaction.

When did Bares Capital Management sell Merck & Company Inc (MRK)?

Bares Capital Management sold off the entire Merck & Company Inc (MRK) position in 2015 Q1.

When did Bares Capital Management buy Merck & Company Inc (MRK)?

Bares Capital Management first invested in Merck & Company Inc (MRK) in 2014 Q1 at the reported quarter-end price of $56.67 per share.

What's the cost basis of Bares Capital Management's MRK stake?

The estimated cost basis for Merck & Company Inc (MRK) stake is around $56.67 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$56.67
Weighted AVG sell price:
$56.67

Bares Capital Management's historical trades in Merck & Company Inc

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2015 Q1
0.00%
$56.67
-100% (-3,794)
2014 Q1
0.02%
$56.67
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.